# A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease

> **NCT03384966** · PHASE2 · COMPLETED · sponsor: **Viatris Innovation GmbH** · enrollment: 346 (actual)

## Conditions studied

- Stable Coronary Artery Disease

## Interventions

- **DRUG:** Selatogrel
- **DRUG:** Placebo
- **DRUG:** Selatogrel

## Key facts

- **NCT ID:** NCT03384966
- **Lead sponsor:** Viatris Innovation GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-24
- **Primary completion:** 2018-08-18
- **Final completion:** 2018-09-18
- **Target enrollment:** 346 (ACTUAL)
- **Last updated:** 2025-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03384966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03384966, "A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03384966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*